BioMerieux Fully Acquires Canada Tech Biz Lumed For €9M
French biotechnology company BioMerieux said Monday that it has boosted its 16% stake in a Canadian clinical software business to 100% for approximately €9 million ($9.8 million) in a move to...To view the full article, register now.
Already a subscriber? Click here to view full article